Pfizer's $7.3B Metsera Deal Aims to Trim Lilly & Novo’s Lead in Obesity Race
Pfizer is acquiring weight-loss drug developer Metsera in a deal valued at up to $7.3 billion as it tries to catch up in the booming obesity treatment market.
More Videos
Inside Five Star Franchising's Plan to Help the Next Generation of Business Owners
Five Star Franchising CEO Scott Abbott explains why Millennials and Gen Z are embracing franchise ownership and what it means for the future of work.
Businesses Older Than America: 250+ Year Old Companies Still Going Strong
These three American businesses existed before the country itself, and they're still thriving!
The World Cup Isn't Just a Tournament, It's a $41 Billion Business
The 2026 FIFA World Cup is more than just a tournament. With over 6.5 million fans expected to attend, it's become one of the world's largest economic events.
The Battle for Your Screen: What's Next for TV and Streaming?
Variety Senior TV Editor Brian Steinberg breaks down media mergers, streaming, cord-cutting, and the biggest trends reshaping the future of television.
Cracks in the Musk Empire? Tesla Stumbles as SpaceX Faces New Questions
Pulitzer Prize-winning Wall Street Journal reporter Becky Peterson breaks down Tesla's latest earnings, SpaceX, and what's next for Elon Musk.
Inside the Surprising Locations Where AI Data Centers Could Be Built
As AI demand surges, LT350 is reimagining parking lots as data centers. Founder and CEO Jeff Thramann explains this innovative approach to AI infrastructure.
